Astrazeneca ADR Aktie
75,00 €
Deine Einschätzung
Astrazeneca ADR Aktie
Was spricht für und gegen Astrazeneca ADR in den nächsten Jahren?
Pro
Kontra
Rendite von Astrazeneca ADR im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Astrazeneca ADR | 0,67 % | 1,35 % | 4,17 % | 8,70 % | 21,95 % | 54,32 % | - |
GSK plc ADR | -0,52 % | 0,52 % | -8,57 % | 19,25 % | 14,29 % | -7,47 % | -12,81 % |
Bayer AG ADR | -1,49 % | -11,41 % | -5,04 % | -47,62 % | -23,26 % | -51,11 % | -50,38 % |
Novo Nordisk A/S ADR | 0,00 % | 2,71 % | 10,88 % | -10,17 % | 41,26 % | 89,83 % | 190,57 % |
Kommentare
https://www.nasdaq.com/articles/is-it-too-late-to-buy-the-most-promising-pipeline-in-the-pharma-industry-2021-05-28
News
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
AstraZeneca (NASDAQ: AZN), recognized as the world's sixth-largest pharmaceutical entity by market capitalization, made a bold proclamation in May 2014. The company set an ambitious goal of
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
AstraZeneca (NASDAQ: AZN) is embarking on a fresh business plan that will see it grow significantly between now and 2030. If it succeeds, it'll be a company that's even more prominent in the global
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Many healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend stock. But I see an investment that's full of uncertainty and risk.
The company continually runs into